Identifying SARS-CoV-2 epitopes targeted by current vaccination could help improve future vaccines

By | May 28, 2021
Researchers in the United States have identified antibody-inducing epitopes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals vaccinated against coronavirus disease 2019 (COVID-19) that could be used for future diagnostics, therapeutics, and vaccine design.